Skip to main content

Table 1 Summary of the AD, old and young cohorts

From: Pyroglutamate and Isoaspartate modified Amyloid-Beta in ageing and Alzheimer’s disease

Case Gender Age at death APOE status Braak stage Dementia duration (years)
AD 15F:12M 63–88 20ε4+: 5ε4_ IV-VI 3–17
OC (n = 32) 16F:16M 64–97 5ε4+: 27ε4_ 0-III n/a
YC (n = 11) 6F:5M 26–62 n/d n/d n/a
  1. n/a non-applicable
  2. n/d non-determined